Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024

 
• By Joseph Haas
  
Eye
Aldeyra will launch new Phase III study in dry eye to respond to FDA CRL
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D